Apr 20 2012
The Center for Global Health Policy's "Science Speaks" blog examines a memorandum (.pdf) from the Foundation for AIDS Research (amfAR), distributed "to a targeted list of congressional leaders with jurisdiction over PEPFAR or the appropriations committees that fund it," "that makes the case for continued funding for the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program at least at fiscal year (FY) 2012 funding levels." The blog uses the "HIV/AIDS funding summaries [.pdf] of the Department of State Congressional Budget Justification for Foreign Operations" and a recent report from Medecins Sans Frontieres (MSF) to examine how budget cuts and a funding shortfall for the Global Fund to Fight AIDS, Tuberculosis and Malaria may affect funding for the Democratic Republic of Congo, Ethiopia, and Kenya (Mazzotta, 4/18).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Semaglutide improves heart health and reduces weight in obese patients, but with side effects